Fortis Advisors, LLC Dexcom Inc Transaction History

Fortis Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $36,855 - $61,939	-588 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $28,100 - $44,470	588 New	588 $158,000
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $37,838 - $51,466	-1,348 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $36,382 - $50,374	1,348 New	1,348 $161,000

1,085

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.